IDEAYA Biosciences, Inc. (IDYA) Net margin 2020–2025
IDEAYA Biosciences, Inc. (IDYA) net profit margin by fiscal year — reported net income divided by reported revenue.
-52.0%FY2025 · since FY2020: -176.6% → -52.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -52.0% | +3869.1 pp |
| FY2024 | -3921.1% | -3438.1 pp |
| FY2023 | -483.0% | -367.9 pp |
| FY2022 | -115.2% | +62.9 pp |
| FY2021 | -178.1% | -1.5 pp |
| FY2020 | -176.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More IDYA financial trends
IDYA RevenueIDYA Net incomeIDYA Gross profitIDYA Gross marginIDYA Operating incomeIDYA Operating marginIDYA Operating cash flowIDYA Free cash flowIDYA Capital expendituresIDYA Return on equityIDYA Stock buybacksIDYA Dividends paidIDYA Total assetsIDYA Total liabilitiesIDYA Shareholders’ equityIDYA overview →